DRAP Draft Guidance on Clinical Research: Specific Aspects
The new article highlights the aspects of clinical research concerning the products intended to be marketed and used in Pakistan.
The new article highlights the aspects of clinical research concerning the products intended to be marketed and used in Pakistan.
The new article describes in detail the regulatory approach to be followed when reviewing the applications related to clinical investigations to be conducted in Pakistan.
The new article highlights the critical points related to the application process, outlining the key steps to be taken when applying for approval in a clinical investigation.
The new article describes in detail the key responsibilities of the parties involved in clinical research.
The article provides a general overview of Pakistan’s regulatory requirements for clinical research.